Here is my current top ranked sectors from amongst the 60 that I track:
Data from Best Stocks Now App
The pharmaceutical sector, as seen by the SPDR S&P Pharmaceuticals (XPH) ETF, is up over 54% year to date, while biotechs (iShares Nasdaq Biotechnology Index (IBB)) are up 52%, and the Internet sector (First Trust DJ Internet Index Fund (FDN)) is up 42%.
That brings me back to a stock that I own at Gunderson Capital Management, Akorn.Data from Best Stocks Now App The company, which is headquartered in Lake Forest, Ill., develops pharmaceuticals in specialty areas such as ophthalmology, hospital drugs and injectables. Earnings growth over the last five years has averaged about 32% per year and the company is expected to continue to grow by about 20% per year over the next five years. The old adage goes that from little acorns grow mighty oaks. Akorn is a $2 billion company now. When I first started following AKRX it was only a $1 billion company. Who knows how much bigger it is going to get? It was a little acorn, now it is a much larger acorn. Will it ever be a mighty oak? I don't know, but it is sure doing well right now and I'm very happy so far with my position in the stock. While earnings growth is nice, I demand the stocks that I own be top performers as it relates to the rest of the stocks in the market. I like to invest in leaders and not laggards. Performance Data from Best Stocks Now App This stock has been a terrific performer. Over the last 10 years the stock has delivered almost 27% per year to investors while the market has delivered 5.5% per year. Over the last five years AKRX has delivered almost 62% per year while the market has delivered 15% per year. Over the last three years AKRX has continued to deliver 58% per year while the market has delivered 14%. And over the last 12 months AKRX is up 73% while the market is only up 32%! When I compare the performance of AKRX against the more than 3,600 stocks that I track, Akorn gets a performance grade of 'A+'. It is one of the rare stocks that gets such a high grade. It also gets a momentum grade of 'A'.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV